168 related articles for article (PubMed ID: 20876521)
1. In situ detection of active transglutaminases for keratinocyte type (TGase 1) and tissue type (TGase 2) using fluorescence-labeled highly reactive substrate peptides.
Itoh M; Kawamoto T; Tatsukawa H; Kojima S; Yamanishi K; Hitomi K
J Histochem Cytochem; 2011 Feb; 59(2):180-7. PubMed ID: 20876521
[TBL] [Abstract][Full Text] [Related]
2. Identification of a preferred substrate peptide for transglutaminase 3 and detection of in situ activity in skin and hair follicles.
Yamane A; Fukui M; Sugimura Y; Itoh M; Alea MP; Thomas V; El Alaoui S; Akiyama M; Hitomi K
FEBS J; 2010 Sep; 277(17):3564-74. PubMed ID: 20716179
[TBL] [Abstract][Full Text] [Related]
3. Identification of preferred substrate sequences for transglutaminase 1--development of a novel peptide that can efficiently detect cross-linking enzyme activity in the skin.
Sugimura Y; Hosono M; Kitamura M; Tsuda T; Yamanishi K; Maki M; Hitomi K
FEBS J; 2008 Nov; 275(22):5667-77. PubMed ID: 18959752
[TBL] [Abstract][Full Text] [Related]
4. Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA.
Sugimura Y; Hosono M; Wada F; Yoshimura T; Maki M; Hitomi K
J Biol Chem; 2006 Jun; 281(26):17699-706. PubMed ID: 16636049
[TBL] [Abstract][Full Text] [Related]
5. FRET-based detection of isozyme-specific activities of transglutaminases.
Tatsukawa H; Liu HH; Oba S; Kamiya N; Nakanishi Y; Hitomi K
Amino Acids; 2017 Mar; 49(3):615-623. PubMed ID: 27586957
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of substrates crosslinked by transglutaminases in liver and kidney fibrosis.
Tatsukawa H; Takeuchi T; Shinoda Y; Hitomi K
Anal Biochem; 2020 Sep; 604():113629. PubMed ID: 32061735
[TBL] [Abstract][Full Text] [Related]
7. Identification of a highly reactive substrate peptide for transglutaminase 6 and its use in detecting transglutaminase activity in the skin epidermis.
Fukui M; Kuramoto K; Yamasaki R; Shimizu Y; Itoh M; Kawamoto T; Hitomi K
FEBS J; 2013 Mar; 280(6):1420-9. PubMed ID: 23331848
[TBL] [Abstract][Full Text] [Related]
8. Preferred substrate sequences for transglutaminase 2: screening using a phage-displayed peptide library.
Hitomi K; Kitamura M; Sugimura Y
Amino Acids; 2009 Apr; 36(4):619-24. PubMed ID: 18651094
[TBL] [Abstract][Full Text] [Related]
9. GTP, an inhibitor of transglutaminases, is hydrolyzed by tissue-type transglutaminase (TGase 2) but not by epidermal-type transglutaminase (TGase 3).
Hitomi K; Ikura K; Maki M
Biosci Biotechnol Biochem; 2000 Mar; 64(3):657-9. PubMed ID: 10803976
[TBL] [Abstract][Full Text] [Related]
10. Variations in both TG1 and TG2 isozyme-specific in situ activities and protein expressions during mouse embryonic development.
Itoh M; Tatsukawa H; Eun-Seo L; Yamanishi K; Kojima S; Hitomi K
J Histochem Cytochem; 2013 Nov; 61(11):793-801. PubMed ID: 23896968
[TBL] [Abstract][Full Text] [Related]
11. Novel site-specific immobilization of a functional protein using a preferred substrate sequence for transglutaminase 2.
Sugimura Y; Ueda H; Maki M; Hitomi K
J Biotechnol; 2007 Aug; 131(2):121-7. PubMed ID: 17658645
[TBL] [Abstract][Full Text] [Related]
12. Characterization of amine donor and acceptor sites for tissue type transglutaminase using a sequence from the C-terminus of human fibrillin-1 and the N-terminus of osteonectin.
Khew ST; Panengad PP; Raghunath M; Tong YW
Biomaterials; 2010 Jun; 31(16):4600-8. PubMed ID: 20223517
[TBL] [Abstract][Full Text] [Related]
13. Structural and transglutaminase substrate properties of the small proline-rich 2 family of cornified cell envelope proteins.
Tarcsa E; Candi E; Kartasova T; Idler WW; Marekov LN; Steinert PM
J Biol Chem; 1998 Sep; 273(36):23297-303. PubMed ID: 9722562
[TBL] [Abstract][Full Text] [Related]
14. Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis.
Shin DM; Jeon JH; Kim CW; Cho SY; Kwon JC; Lee HJ; Choi KH; Park SC; Kim IG
J Biol Chem; 2004 Apr; 279(15):15032-9. PubMed ID: 14752105
[TBL] [Abstract][Full Text] [Related]
15. Gene disruption of tissue transglutaminase.
De Laurenzi V; Melino G
Mol Cell Biol; 2001 Jan; 21(1):148-55. PubMed ID: 11113189
[TBL] [Abstract][Full Text] [Related]
16. Screening of substrate peptide sequences for tissue-type transglutaminase (TGase 2) using T7 phage cDNA library.
Sugimura Y; Yamashita H; Hitomi K
Cytotechnology; 2011 Mar; 63(2):111-8. PubMed ID: 20865325
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster.
Park SS; Kim JM; Kim DS; Kim IH; Kim SY
J Biol Chem; 2006 Nov; 281(46):34965-72. PubMed ID: 16987813
[TBL] [Abstract][Full Text] [Related]
18. Ca2+: a stabilizing component of the transglutaminase activity of Galphah (transglutaminase II).
Lee SC; Kim JH; Park ES; Kim DK; Kim YG; Yun HY; Kwon NS; Im MJ; Baek KJ
Mol Cells; 2003 Dec; 16(3):285-90. PubMed ID: 14744016
[TBL] [Abstract][Full Text] [Related]
19. A specific colorimetric assay for measuring transglutaminase 1 and factor XIII activities.
Hitomi K; Kitamura M; Alea MP; Ceylan I; Thomas V; El Alaoui S
Anal Biochem; 2009 Nov; 394(2):281-3. PubMed ID: 19646949
[TBL] [Abstract][Full Text] [Related]
20. Identification of mammalian-type transglutaminase in Physarum polycephalum. Evidence from the cDNA sequence and involvement of GTP in the regulation of transamidating activity.
Wada F; Nakamura A; Masutani T; Ikura K; Maki M; Hitomi K
Eur J Biochem; 2002 Jul; 269(14):3451-60. PubMed ID: 12135484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
